• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安托美汀胍酯对不同胃肠道损伤模型中脂质过氧化和抗氧化防御系统的体内作用。

In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.

作者信息

Kirkova M, Kesiova M, Konstantinova S, Alexandrova A, Petrov L, Tsvetanova E, Todorov S

机构信息

Institute of Physiology, Bulgarian Academy of Sciences, 23 Acad. G. Bonchev St, 1113 Sofia, Bulgaria.

出版信息

Auton Autacoid Pharmacol. 2007 Jan;27(1):63-70. doi: 10.1111/j.1474-8673.2006.00390.x.

DOI:10.1111/j.1474-8673.2006.00390.x
PMID:17199877
Abstract
  1. The in vivo effects of the non-steroid anti-inflammatory drug (NSAID) amtolmetin guacyl (AMG) on lipid peroxidation (LP) and on antioxidant enzyme and non-enzyme defence systems were investigated in models of stomach and colon damages, induced by other NSAIDs, by ethanol or by 2,4,6-trinitrobenzenesulfonic acid (TNBS). 2. Indomethacin increased LP, glutathione peroxidase (GSH-PX) and glucose-6-phosphate dehydrogenase (Glu-6-P-DH) activities and decreased glutathione levels in gastric mucosa. Pretreatment with AMG normalized some of the parameters affected by indomethacin. 3. Treatment of rats with ethanol for 0.5 h led to a decrease in glutathione levels as well as activities of glutathione reductase and Glu-6-P-DH in gastric mucosa. AMG, administered 0.5 h before ethanol, limited the adverse actions of ethanol. 4. Amtolmetin guacyl failed to abolish the TNBS-induced changes in the followed-up parameters in colon mucosa and liver, but additional alterations (as with tolmetin) were not observed. 5. The beneficial profile of AMG in the various experimental models of free radical-induced damage investigated in this study suggests the possibility that this drug might possess antioxidant activity.
摘要
  1. 在由其他非甾体抗炎药、乙醇或2,4,6-三硝基苯磺酸(TNBS)诱导的胃和结肠损伤模型中,研究了非甾体抗炎药安托美汀胍基(AMG)对脂质过氧化(LP)以及抗氧化酶和非酶防御系统的体内作用。2. 吲哚美辛增加了胃黏膜中的LP、谷胱甘肽过氧化物酶(GSH-PX)和葡萄糖-6-磷酸脱氢酶(Glu-6-P-DH)活性,并降低了谷胱甘肽水平。用AMG预处理可使受吲哚美辛影响的一些参数恢复正常。3. 用乙醇处理大鼠0.5小时导致胃黏膜中谷胱甘肽水平以及谷胱甘肽还原酶和Glu-6-P-DH活性降低。在乙醇处理前0.5小时给予AMG,可限制乙醇的不良作用。4. 安托美汀胍基未能消除TNBS诱导的结肠黏膜和肝脏中后续参数的变化,但未观察到其他改变(如托美汀所致)。5. 本研究中在各种自由基诱导损伤的实验模型中AMG的有益表现表明,该药可能具有抗氧化活性。

相似文献

1
In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.安托美汀胍酯对不同胃肠道损伤模型中脂质过氧化和抗氧化防御系统的体内作用。
Auton Autacoid Pharmacol. 2007 Jan;27(1):63-70. doi: 10.1111/j.1474-8673.2006.00390.x.
2
In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.安托美汀胍基酯对脂质过氧化和抗氧化防御系统的体内作用。与非选择性和COX - 2选择性非甾体抗炎药的比较。
Auton Autacoid Pharmacol. 2007 Apr;27(2):99-104. doi: 10.1111/j.1474-8673.2007.00395.x.
3
Potential antioxidant activity of celecoxib and amtolmetin guacyl: in vitro studies.塞来昔布和安吡昔康瓜氨酸酯的潜在抗氧化活性:体外研究
Auton Autacoid Pharmacol. 2007 Jan;27(1):13-8. doi: 10.1111/j.1474-8673.2006.00391.x.
4
Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide.新型抗炎药物安吡昔康对大鼠的胃保护作用:一氧化氮的参与
Dig Dis Sci. 1999 Apr;44(4):713-24. doi: 10.1023/a:1026653623516.
5
Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.新型非甾体抗炎药安托美汀胍酯的胃耐受性研究。
Arzneimittelforschung. 1995 Dec;45(12):1298-302.
6
Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.对猪每日重复口服吲哚美辛及其他非甾体抗炎药的常规制剂后胃肠道黏膜损伤:一种人类胃肠道疾病模型
J Pharm Pharmacol. 2003 May;55(5):661-8. doi: 10.1211/002235703765344577.
7
Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.安托美汀胍基酯的胃保护作用:一种可激活诱导型胃一氧化氮合酶的新型非甾体抗炎药。
Dig Liver Dis. 2002 Jun;34(6):403-10. doi: 10.1016/s1590-8658(02)80037-8.
8
Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.新型胃保护非甾体抗炎药安吡昔康的抗炎和抗血小板作用
Arzneimittelforschung. 2001 Sep;51(9):737-42. doi: 10.1055/s-0031-1300108.
9
Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.安吡昔康与双氯芬酸治疗类风湿关节炎患者的临床及胃镜评估
Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):378-85.
10
Gastroprotective effect and mechanism of amtolmetin guacyl in mice.安吡昔康呱酯对小鼠的胃保护作用及其机制
World J Gastroenterol. 2004 Dec 15;10(24):3616-20. doi: 10.3748/wjg.v10.i24.3616.

引用本文的文献

1
Amtolmetin: A Reappraisal of NSAID with Gastroprotection.安托美汀:一种具有胃保护作用的非甾体抗炎药的重新评估。
Arthritis. 2016;2016:7103705. doi: 10.1155/2016/7103705. Epub 2016 Mar 22.